8 results
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
NEJMsa065779 #Policy #EBM ... Antidepressants #SSRIs ... #Publication #Bias ... Comparison #FDA #NEJM
Here is the graphic TheNNT.com just published from its analysis of the lung cancer CT screening
analysis of the lung cancer ... CT screening data ... #EBM #PrimaryCare ... #LungCancer #Screening
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
NEJMsa065779 #Policy #EBM ... Antidepressants #SSRIs ... #Publication #Bias ... Comparison #FDA #NEJM
Cancer screening: Do the harms outweigh the benefits? #EBM #epidemioliogy #PubilcHealth #PrimaryCare #HONC #Screening #AdverseEffects #Harms
Cancer screening ... #EBM #epidemioliogy ... PrimaryCare #HONC #Screening
Lung Cancer Screening - Decision Aid - Data from the Nelson Trial
Screening for lung cancer in
Lung Cancer Screening ... Nelson Trial Screening ... for lung cancer ... #Screening #DecisionAid ... #NelsonTrial #EBM
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Non–Small-Cell Lung Cancer ... #EBM #Honc #Alectinib ... VisualAbstract #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
Non–Small-Cell Lung Cancer ... #EBM #Honc #PACIFIC ... Durvalumab #NSCLC #NEJM
Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis - Kupperman et al. NEJM 2018

https://www.nejm.org/doi/full/10.1056/NEJMoa1716816
Study
NEJM 2018 https ... biggest causes for concern ... TessaRDavis #EBM ... Infusion #Rates #NEJM